These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 10388992

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The role of incretins. Type 2 diabetes with new beginnings].
    MMW Fortschr Med; 2005 Mar 10; 147(10):48-9. PubMed ID: 15803785
    [No Abstract] [Full Text] [Related]

  • 3. [A therapeutic option for type-2 diabetes. The incretion hormone GLP-1].
    Göke B, Hoppe B, Konrad A, Schirra J.
    Pharm Unserer Zeit; 2002 Mar 10; 31(3):294-9. PubMed ID: 12071126
    [No Abstract] [Full Text] [Related]

  • 4. Potential therapies mimicking the effects of glucagon-like peptide-1 for the treatment of type 2 diabetes.
    Rachman J.
    Diabet Med; 2004 Jan 10; 21 Suppl 1():18-20. PubMed ID: 15088933
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. On combination therapy of diabetes with metformin and dipeptidyl peptidase IV inhibitors.
    Hinke SA, McIntosh CH, Hoffmann T, Kühn-Wache K, Wagner L, Bär J, Manhart S, Wermann M, Pederson RA, Demuth HU.
    Diabetes Care; 2002 Aug 10; 25(8):1490-1; author reply 1491-2. PubMed ID: 12145269
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel "second-generation" approaches for the control of type 2 diabetes.
    Rotella DP.
    J Med Chem; 2004 Aug 12; 47(17):4111-2. PubMed ID: 15293978
    [No Abstract] [Full Text] [Related]

  • 12. ["Glucagon-like peptide I": a therapeutic alternative for diabetes mellitus?].
    Fehmann HC, Göke B.
    Dtsch Med Wochenschr; 1994 Feb 25; 119(8):275-9. PubMed ID: 8112212
    [No Abstract] [Full Text] [Related]

  • 13. Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.
    Nauck MA.
    Horm Metab Res; 2004 Feb 25; 36(11-12):852-8. PubMed ID: 15655719
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glucagon-like peptide: the time is near.
    Huang A, Raskin P.
    Basic Clin Pharmacol Toxicol; 2004 Dec 25; 95(6):249-51. PubMed ID: 15569268
    [No Abstract] [Full Text] [Related]

  • 16. Glucagon-like peptide: a therapeutic glimmer.
    Amiel SA.
    Lancet; 1994 Jan 01; 343(8888):4-5. PubMed ID: 7905051
    [No Abstract] [Full Text] [Related]

  • 17. Glucagon-like peptide 1 and its derivatives in the treatment of diabetes.
    Nauck MA, Meier JJ.
    Regul Pept; 2005 Jun 15; 128(2):135-48. PubMed ID: 15780433
    [Abstract] [Full Text] [Related]

  • 18. New treatments for patients with type 2 diabetes mellitus.
    Wolffenbuttel BH, Graal MB.
    Postgrad Med J; 1996 Nov 15; 72(853):657-62. PubMed ID: 8944206
    [Abstract] [Full Text] [Related]

  • 19. New pharmacological development (alpha glucosidase inhibitors, amylin analogues, GLP-1, thiozolidinediones, short acting insulin analogues).
    Dharmalingam M, Kumar P.
    J Assoc Physicians India; 2001 Jan 25; 49 Spec No():46-9. PubMed ID: 11235605
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.